Keros Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $338.0M
Liabilities Breakdown FY2025
Total Liabilities: $34.9M
Asset Breakdown
Total Assets: $338.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $287.4M | 85.0% |
| Accounts Receivable | $3.6M | 1.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.3M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $42.7M | 12.6% |
Liabilities Breakdown
Total Liabilities: $34.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.0M | 5.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $32.9M | 94.4% |